Sertraline treatment of children and adolescents with posttraumatic stress disorder: A double-blind, placebo-controlled trial

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 6, 2010, Pages 463-471

  Robb, Adelaide S ^a   Cueva, Jeanette E ^b   Sporn, Jonathan ^c   Yang, Ruoyong ^c   Vanderburg, Douglas G ^c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SERTRALINE;

ABDOMINAL PAIN; ACCIDENTAL INJURY; ADOLESCENT; AGITATION; CHILD; CONFERENCE PAPER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSMENORRHEA; FEMALE; HEADACHE; HUMAN; HYPERKINESIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHARYNGITIS; POSTTRAUMATIC STRESS DISORDER; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINITIS; SIDE EFFECT; VOMITING; XEROSTOMIA;

ADOLESCENT; CHILD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 78650673620     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2009.0115     Document Type: Conference Paper

References (40)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR). Washington (DC): American Psychiatric Association, 2000.
2. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM: Efficacy and safety of sertraline treatment of posttrau-matic stress disorder: A randomized controlled trial. JAMA 283: 1837-1844, 2000.
3. Bremner JD, Elzinga B, Schmahl C, Vermetten E: Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res 167:171-186, 2008.
4. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P: Trauma and posttraumatic stress disorder in the community: The 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 55:626- 632, 1998.
5. Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA: Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 166:42-49, 2009.
6. Carrion VG, Weems CF, Reiss AL: Stress predicts brain changes in children: A pilot longitudinal study on youth stress, posttraumatic stress disorder, and the hippocampus. Pediatrics 119:509-516, 2007.
7. Cohen JA, and the Work Group on Quality Issues: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 37:4S-26S, 1998.
8. Cohen JA, Mannarino AP, Perel JM, Staron V: A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. J Am Acad Child Adolesc Psychiatry 46:811-819, 2007.
9. Copeland WE, Keeler G, Angold A, Costello EJ: Traumatic events and posttraumatic stress in childhood. Arch Gen Psychiatry 64:577- 584, 2007.
10. Cuffe SP, Addy C, Garrison CZ, Waller JL, Jackson KL, McKeown RE, Chilappagari S: Prevalence of PTSD in a community sample of older adolescents. J Am Acad Child Adolesc Psychiatry 37:147- 154, 1998.
11. Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G: Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: Results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry 158:1974- 1981, 2001a.
12. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM: Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 58:485-492, 2001b.
13. Davidson JR, Payne VM, Connor KM, Foa EB, Rothbaum BO, Hertzberg MA, Weisler RH: Trauma, resilience and saliostasis: Effects of treatment in post-traumatic stress disorder. Int Clin Psy-chopharmacol 20:43-48, 2005.
14. Endicott J, Nee J, Yang R, Wohlberg C: Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q): Reliability and validity. J Am Acad Child Adolesc Psychiatry 45:401-407, 2006.
15. Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM: Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry 68:711-720, 2007.
16. Giaconia RM, Reinherz HZ, Silverman AB, Pakiz B, Frost AK, Cohen E: Traumas and posttraumatic stress disorder in a community population of older adolescents. J Am Acad Child Adolesc Psychiatry 34:1369-1380, 1995.
17. Guy W: ECDEU Assessment Manual for Psychopharmacology. Washington, D.C.: National Institute of Mental Health-U.S. Department of Health, Education, and Welfare publication (ADM), pp 276-338, 1976.
18. Hawkins SS, Radcliffe J: Current measures of PTSD in children and adolescents. J Ped Psychol 31:420-430, 2006.
19. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
20. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB: Post-traumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52:1048-1060, 1995.
21. March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H: Sertraline in children and adolescents with obsessive-compulsive disorder: A multi-center randomized controlled trial. JAMA 280:1752-1756, 1998.
22. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J: Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292:807-820, 2004.
23. Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA, Duan W: The antidepressant sertraline improves the phenotype, promotes neuro-genesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp Neurol 210:154-163, 2008.
24. Perkonigg A, Kessler RC, Storz S, Wittchen H-U: Traumatic events and post-traumatic stress disorder in the community: Prevalence, risk factors and comorbidity. Acta Psychiatr Scand 101:46-59, 2000.
25. Pervanidou P: Biology of post-traumatic stress disorder in childhood and adolescence. J Neuroendocrinol 20:632-638, 2008.
26. Pittenger C, Duman RS: Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology 33:88- 109, 2008.
27. Poznanski EO, Mokros HB: Children's Depression Rating Scale, Revised (CDRS-R) Manual. Western Psychological Services, 1995.
28. Pynoos R, Rodriquez N, Steinberg A, Stuber M, Frederick C: UCLA PTSD Index for DSM-IV (Revision 1). Available on request from UCLA Trauma Psychiatry Service, 300 UCLA Medical Plaza, Ste 2232, Los Angeles, CA 90025-6968, 1998.
29. Rynn MA, Siqueland L, Rickels K: Placebo-controlled trial of ser-traline in the treatment of children with generalized anxiety disorder. Am J Psychiatry 158:2008-2014, 2001.
30. Saxe G, Chawla N, Stoddard F, Kassam-Adams N, Courtney D, Cunningham K, Lopez C, Hall E, Sheridan R, King D, King L: Child Stress Disorders Checklist: A measure of ASD and PTSD in children. J Am Acad Child Adolesc Psychiatry 42:972-978, 2003.
31. Seedat S, Lockhat R, Kaminer D, Zungu-Dirwayi MZ: An open trial of citalopram in adolescents with post-traumatic stress disorder. Int Clin Psychopharmacol 16:21-26, 2001.
32. Seedat S, Stein DJ, Ziervogel C, Middleton T, Kaminer D, Emsley RA, Rossouw W: Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. J Child Adolesc Psychopharmacol 12:37-46, 2002.
33. Smith ME: Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: A meta-analysis of structural MRI studies. Hippocampus 15:798-807, 2005.
34. Stein DJ, van der Kolk BA, Austin C, Fayyad R, Clary C: Efficacy of sertraline in posttraumatic stress disorder secondary to interpersonal trauma or childhood abuse. Ann Clin Psychiatry 18:243-249, 2006.
35. Steinberg AM, Brymer MJ, Decker KB, Pynoos RS: The University of California at Los Angeles Post-Traumatic Stress Disorder Reaction Index. Curr Psychiatr Reports 6:96-100, 2004.
36. Tupler LA, De Bellis MD: Segmented hippocampal volume in children and adolescents with posttraumatic stress disorder. Biol Psychiatry 59:523-529, 2006.
37. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Green-baum MS, Childress A, Donnelly C, Deas D: Sertraline Pediatric Depression Study Group. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. JAMA 290:1033-1041, 2003.
38. Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, Ginsburg GS, Rynn MA, McCracken J, Waslick B, Iyengar S, March JS, Kendall PC: Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 359:2753-2766, 2008.
39. Warner-Schmidt JL, Duman RS: Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus 2006;16:239-249.
40. Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, Austin C: Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psy-chopharmacol 22:190-195, 2002.